REQUEST A DEMO
Total
USD $0.00
Search more companies

Wd Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: All Other Nondepository Credit Intermediation
Full name: Wd Pharma Sp. z o.o. Profile Updated: March 05, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Wd Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was first established on February 20, 2012. There are currently 1 (2013) people employed by Wd Pharma Sp. z o.o.. Its total assets grew by 2.05% over the same period.

Headquarters
Ul. Suwalska 8/177
Warsaw; Mazowieckie; Postal Code: 03-252

Contact Details: Purchase the Wd Pharma Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Wd Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Wd Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Wd Pharma Sp. z o.o. report to view the information.
Incorporation Date:
February 20, 2012
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
49.5%
Purchase this report to view the information.
49.5%
Subsidiaries
"Celther Polska" Sp. z o.o.
80%
Przedsiebiorstwo Farmaceutyczne Lek-Am Investments Sp. z o.o.
50%
Company Performance
Financial values in the chart are available after Wd Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total Operating Revenue
-100%
Operating Profit
24.94%
Net Profit/Loss for the Period
2.6%
Total Assets
2.05%
Total Equity
0.9%
Return on Equity (ROE)
0.01%
Quick Ratio
-1.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?